Osamu Nagayama

CV as per end of term

Zur deutschen Version

Personal Data

Nationality
Japanese

Year of Birth
1947

Position

Chairman of the Board of Directors Pharmaceutical Co., Ltd. of Chugai

Studies

Faculty of Business and Commerce, Keio University

Professional Career

1971

The Long-Term Credit Bank of Japan

1975

London Branch, The Long-Term Credit Bank of Japan

1978

Chugai Pharmaceutical Co., Ltd.

1983

Director, Pharmaceutical Sales & Marketing Division and International Business Division

1985

Deputy General Manager, Pharmaceutical Research and Development Division, Member of the Board of Directors

1986

Deputy General Manager, Personal Healthcare Division

1987

Senior Vice President

1989

Deputy President

1992

President and CEO

2012

Chairman and CEO

2018

Chairman (to present)

Other Activities / Memberships

since 2010
Member of the Board of Directors of Sony Corporation
since 2013
Chairman of the Board of Sony Corporation

Möchten Sie den Inhalt auf Deutsch lesen?

Zur deutschen Version

About Roche

Discover more

Our approach to sustainabilityAbout Roche

Sustainability is integrated into Roche’s corporate vision, values, operating standards and guidelines. This approach means no single department is responsible for managing sustainability.

Code of conductAbout Roche

The Roche Group Code of Conduct states the expectations Roche as an employer has towards his employees and sets forth the standards for business behaviour that apply throughout the Roche Group.

InvestorsInvestors

We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.

Board CommitteesAbout Roche

Our Board of Directors has delegated certain matters to four committees for detailed attention.

Executive CommitteeAbout Roche

The Executive Committee's composition and the curricula vitae of its members.

Articles of Incorporation & BylawsAbout Roche

Our Articles of Incorporation contain the principal information on Roche's business purpose, structures and statutory bodies.